Dishman Pharmaceuticals and Chemicals has posted a 44.49 per cent dip in consolidated net profit to Rs 15.12 crore for the quarter ended June 30, 2011.
The net profit stood at Rs 27.24 crore during the same period in the previous financial year, Dishman Pharmaceuticals said in a filing to the Bombay Stock Exchange.
Total income rose to Rs 242.77 crore from Rs 212.27 crore.
Meanwhile, the company shares were being quoted at Rs 89 in the late afternoon trade on the BSE, down 1.87 per cent from the previous close.